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Abstract.  Intracisternal granules (ICG) develop in the 
rough ER of hyperstimulated thyrotrophs or thyroid 
hormone-secreting cells of the anterior pituitary gland. 
To determine the fate of these granules, we carried 
out morphological and immunocytochemical studies 
on pituitaries of thyroxine-treated, thyroidectomized 
rats.  Under these conditions the ER of thyrotrophs is 
dramatically dilated and contains abundant ICG; the 
latter contain B subunits of thyrotrophic hormone 
(TSH-B).  Based on purely morphologic criteria, inter- 
mediates were identified that appeared to represent 
stages in the transformation of a part rough/part 
smooth ER cisterna into a lysosome. Using immuno- 
cytochemical and cytochemical markers, two major 
types of intermediates were distinguished: type 1 
lacked ribosomes but were labeled with antibodies 
against both ER markers (PDI, KDEL, ER membrane 
proteins) and a lysosomal membrane marker, lgpl20. 
They also were reactive for the lysosomal enzyme, 
acid phosphatase, by enzyme cytoehemistry. Type 2 
intermediates were weakly reactive for ER markers 
and contained both lgpl20 and lysosomal enzymes 
(cathepsin D, acid phosphatase). 
Taken together these results suggest that in hyper- 
stimulated thyrotrophs part rough/part smooth ER ele- 
ments containing ICG lose their ribosomes, their 
membrane is modified, and they sequentially acquire a 
lysosome-type membrane and lysosomal enzymes. The 
findings are compatible with the conclusion that a 
pathway exists by which under certain conditions, 
secretory proteins present in the ER as well as ER 
membrane and content proteins can be degraded by di- 
rect conversion of ER cisternae into lysosomes. 
C 
URRENTLY there is great interest in the mechanisms 
of protein degradation in the ER. It has become ap- 
parent that newly synthesized proteins, primarily un- 
assembled subunits of multimeric proteins or those that are 
in  some way defective  (misfolded,  aggregated,  etc.) and 
therefore transport incompetent, are degraded in the ER (1, 
13,  14). Relatively  little  is known about the pathways by 
which either defective proteins in transit or resident ER 
membrane and luminal proteins are disposed  of, but both 
lysosomal (27, 32) and nonlysosomal (1, 14, 15, 23) mecha- 
nisms have been proposed.  The best documented lysosomal 
disposal route is via autophagy which involves sequestration 
of ER dements by an enveloping smooth membrane proba- 
bly derived from the ER (2, 6, 7, 12). Tooze et al. (32) have 
demonstrated that intracisternal granules (ICG) ~  which de- 
velop within the ER of CoCl~-treated exocrine pancreatic 
cells are eliminated by autophagy. However, some time ago 
we obtained morphological and cytochemical  evidence sug- 
gesting that ICG which develop within the ER of thyrotrophs 
of the rat anterior pituitary are disposed of by a seemingly 
1. Abbreviations used in du's paper:  AePase, acid phosphatase;  ICG, in- 
tracisternai  granules;  PDI, protein  disulfide  isornerase;  PLP, periodate- 
lysine-paraformaldeh3xle; MPR, mannose-6-phosphate  receptor;  1"4, Thy- 
roxine; TSH, thyroid stimulating hormone. 
different lysosomal  mechanism that  does not involve au- 
tophagy (8, 9). ICG form in thyrotrophs when secretion of 
thyrotrophic  hormone  (TSH)  is  first  hyperstimulated  by 
thyroidectomy, and then abruptly stopped by treatment with 
thyroxine (1"4). These granules cannot traverse the exocytic 
pathway and are disposed of. 
To obtain  further information on the nature of this lyso- 
somal mechanism for disposal of ICG we have studied the 
distribution of ER resident proteins, a lysosomal membrane 
protein,  and lysosomal enzymes in thyrotrophs containing 
ICG by immunofluorescence and by immunogold labeling. 
Our results provide evidence suggesting that regions of the 
RER shed their ribosomes and are directly converted into ly- 
sosomes by acquiring  a lysosome-like membrane followed 
by accumulation  of lysosomal enzymes. 
Materials and Methods 
Materials 
L-thyroxine (sodium salt), polyvinyl alcohol (mol wt =  10,000), andpoly- 
vinylpyrrolidone (tool wt =  10,000) were obtained  from Sigma Chemical 
Co. (St. Louis, MO). F(ab')2 fragments of goat anti-rabbit  IgG conjugated 
to rhodamine  were obtained  from TAGO, Inc.  (Burlingame,  CA).  Goat 
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Janssen Life Science Products (Piscataway, NJ), Amersham Corp. (Arling- 
ton Heights, IL) or BioCeU Research Laboratories  (Cardiff, UK). Protein 
A was obtained  from Pharmacia  Fine Chemicals  (Piscataway, NJ),  gold 
chloride from Fisher Scientific (Fair Lawn, NJ), and tannic acid from Mai- 
linkrodt (St. Louis,  MO).  Gold particles  were prepared  according to the 
method of Frens (15 nm) (11) or Slot and Geuze (5-10 nm) (24) and con- 
jugated to protein A (25). 
Animals 
Thyroidectomized  Sprague-Dawley rats (100-150 g) were purchased from 
Harlan Sprague Dawley, Inc. (Indianapolis,  IN). 40-43 d after the opera- 
tion,  T4 (10/~g/100 g body weight) was injected subcutaneously  daily for 
1-4 d. Animals were sacrificed on the second to fifth day after initiating the 
T4 injection. 
Antibodies 
Rabbit antiserum against the bovine TSH-13 subunit (Midas) was obtained 
from Dr. I. A. Kourides (Memorial  Sloan-Kettering Cancer Center, NY). 
Rabbit  antiserum  against  ovine  LH-c~ subunits  (which  also  recognizes 
TSH-c0 was provided by Dr. James A. Magnet (Michael Reese Hospital 
and Medical Center, Chicago, IL) (19). A rabbit antiserum that recognizes 
four ER membrane proteins (29, 58, 66, and 91 kD) was from Dr. Daniel 
Louvard (Pasteur  Institute,  Paris,  France)  (16). Rabbit antiserum  against 
bovine protein disulfide isomerase (PDI), and mouse monoclonal IgG (ID3) 
against a  KDEL-containing  peptide  (KDDDKAVKDEL) were  from Dr. 
Stephen Fuller, European Molecular Biology Laboratory (Heidelberg, Ger- 
many) (31). Affinity purified rabbit antibody raised against cathepsin D and 
acid phosphatase (Acpase) from rat liver were provided by Dr. Keitaro Kato 
(Kyushu University, Fukuoka, Japan) (34), and rabbit antiserum against rat 
liver lgpl20 was from Dr.  William A. Dunn,  Jr. (University of Florida, 
Gainesville, FL) (6). Rabbit IgG raised against the cation-independent man- 
nose-6-phosphate/insulin-like  growth factor II (MPR) receptor was charac- 
terized  previously  (4).  A  second  rabbit  antibody against  MPR receptor 
was kindly provided by Dr. Michael Czech (University of Massachusetts, 
Boston,  MA). 
Preparation of 7Issue  for Morphology 
and lmmunocytochemistry 
Rats were perfused under anesthesia first with physiological saline for 3-5 
min and then with either (a) periodate-lysine-paraformaldehyde  (PLP) fixa- 
tive (20); (b) 3% paraformaldehyde, 3% glutaraldehyde in 0.1 M cacodylate 
buffer, pH 7.4; or (c) 3 % paraformaldehyde, 0.05 % glutaraldebyde in 0.1 M 
phosphate buffer, pH 7.4, for •5  rain. The pituitary was removed, the an- 
terior lobe trimmed  into  l-ram  3 blocks,  and the  tissue  blocks were im- 
mersed in the same fixatives for 6, 2, or 1 h, respectively. 
For morphology  alone,  tissue  blocks  were postfixed  in  1%  OsO4 in 
acetate-veronal buffer, stained in block in 0.5% uranyl acetate (pH 6.0) fol- 
lowed by dehydration in ethanol and embedding in Epox. A few blocks were 
postfixed in 1.5% potassium  ferrocyanide containing  1% OsO4 for 1-2 h, 
followed by staining in block in 0.5%  aqueous uranyl acetate prior to de- 
hydration and embedding. 
For cryosectioning,  tissue blocks were infiltrated with 50% polyvinyl- 
pyrrolidone in 2.3 M sucrose-PBS for 2 h at room temperature or overnight 
at 4~  They were then mounted on aluminum nails, frozen in Freon cooled 
by liquid nitrogen, and then in liquid nitrogen. Semithin (0.5 ~,m) or ultra- 
thin cryosections were cut from frozen tissue blocks with an Ultracut  E 
ultramicrotome  equipped with a cryo-attachment  (model FC4E; Reichert 
Jung S. A., Vienna) using the methods of Tokuyasu (29). 
For enzyme cytochemicai demonstration of AcPase, pituitary glands of 
rats were perfused with 1.5 % ghtaraidehyde in 0.067 M cacodylate buffer, 
pH 7.4, containing  1% sucrose; the pituitary  was removed and immersed 
in fresh fixative for an addition~ 2 h. Non-frozen sections were cut at 10-40 
~m with a Smith-Farquhar TC-II Tissue Chopper (Ivan Sorvall, Inc., New- 
ton, CT) (26). Sections were collected in 0.1 M cacodylate buffer, pH 7.4, 
containing 7% sucrose. 
Immunofluorescence 
Semithin cryosections were placed on gelatin-coated glass slides, quenched 
with 50 mM NI-I4CI  for 10 min, and incubated in primary antibody in 10% 
FCS in PBS for 2 h at room temperature,  followed by TRITC- or FITC- 
conjugated goat anti-rabbit F(ab')2 for 1 h at room temperature.  Sections 
were mounted in 90 % glycerol in PBS containing 0.1% p-phenylenediamine 
and examined by epifluorescence with a Photomicroscope  HI (Carl Zeiss, 
Oberkochen,  Germany). 
Immunogold Labeling 
Ultrathin cryosections were collected on formvar and carbon-coated,  glow- 
discharged nickel grids (29) and incubated on droplets of primary antibodies 
diluted  with  10% FCS in PBS. The incubation times were  1 h for anti- 
Acpase, anti-cathepsin D, anti-LH-c~ subunit and anti-TSH-~ subunit anti- 
bodies, and 5 h to overnight for anti-lgpl20, anti-ER, anti-PDI, anti-KDEL, 
and anti-MPR.  After several rinses, the sections were incubated with 5 or 
10 nm goat anti-rabbit  IgG or 6-8 nm protein A-gold conjugate diluted in 
10% FCS in PBS for 0.5-1.0 h. 
For double labeling, the sections were incubated with the primary anti- 
body followed by incubation with 5 or 8 nm protein A-gold. The sections 
were then washed and incubated with free protein A (0.5 mg/ml) diluted in 
PBS containing 10% FCS for 30 rain after which they were incubated with 
the second antibody, followed by 8-15 nm protein  A-gold. Sections were 
fixed with 2% ghtaraldehyde  in PBS (10 rain), postfixed in 1-2% aqueous 
OsO4 (10 rain),  and stained  in 2%  aqueous uranyl acetate  (15-20  min). 
Embedding and adsorption staining was done in 3 % polyvinyl alcohol con- 
taining  0.001-0.002 % lead citrate  according  to Tolmynsu (30). Sections 
were examined at 80 kV in either a Philips 410 (Philips Electronic Instru- 
ments, Mahwah, N  J) or JEOL 1200-EXH (JEOL USA, Peabody, MA) elec- 
tron microscope. 
AcPase Cytochemistry 
After an overnight wash at 4~  non-frozen  sections were incubated  for 
20-90 rain in Gomori medium, pH 5.0, as modified by Barka and Anderson 
(3) using/3-glycerophosphate as substrate and lead nitrate as capture agent 
(26).  Sections were postfixed at 4~  for 45 rain  in 1%  0,04 in 0.05 M 
acetate-Veronai buffer, pH 7.4, stained for 30--45 rain at room temperature 
with 0.5 % uranyl acetate in acetate-Veronal buffer, pH 6.0, before dehydra- 
tion and embedding in Epon. Thin sections were stained with lead citrate. 
Figure 1. Thymtrophs from the pituitaries of thyroidectomized, T4 (4 d)-treated rats as seen in semithin cryosections (.4 and B) and Epon- 
embedded tissue (C and D).  (A) Phase contrast micmgraph showing thymtrophs  (T) with enlarged vacuoles that correspond to dilated 
ER cisternae (er). (B) Immunofluorescence showing the same field labeled for PDI, an ER content marker, demonstrating the presence 
of PDI in the enlarged ER of the thyrotrophs (arrows). (C and D) A number of vacuolated ER cisternae (er) containing dense ICG (arrvw- 
heads) as well as lysosomes (ly) containing barely recognizable remnants of ICG are seen. Also present are structures which appear to 
be intermediate in their characteristics between ER cistemae and lysosomes. Early intermediates (Type  1) contain dense, tightly packed 
ICG surrounded by a narrow, electron-lucent space filled with finely granular material.  Late intermediates (Type 2) differ in that their 
contained ICG are less compact and their remaining contents more condensed. In C it can be seen that ER cisternae containing ICG typically 
have a part rough/part smooth membrane with clusters of ribosomes (arrows) separated by smooth regions lacking ribosomes. Note that 
ICG are in general much larger (,,0200-500 vs. ,~100-200 nm) than secretion granules (st). (A and B) Tissue was fixed in 3 % formaldehyde, 
0.5% ghtaraldehyde,  and prepared for cryomicrotomy. (C) Tissue was fixed in 2%  formaldehyde, 3% glutaraldehyde and postfixed in 
OsO4 before Epon embedding.  (D) Tissue fixed as in A and B  followed by reduced OsO4 and embedding in Epon.  G, Golgi apparatus. 
Bars:  (.4 and B) 5/~m; (C and D) 0.1  /~m. 
The Journal of Cell Biology. Volume 119. 1992  86 Noda and Farquhar Diversion of ER Proteins to Lysosomes  87 Figure 2. (A) Enlargement of membranes of the ER (er) and an early (Type 1 ) intermediate in Epon-embedded tissues. The limiting mem- 
brane of the latter (arrows) is thicker than that of the ER membrane (arrowheads) and is comparable to that of lysosomes. (B) Structure 
which appears to have arisen by fusion of  a type-1 intermediate containing compact ICG (below  arrow) and a type 2 intermediate containing 
more dispersed ICG (above arrow), sg, secretion granule. Tissue fixed in formaldehyde-glutaraldehyde followed by reduced Os04 to en- 
hance membrane staining. Ribosomes are not well visualized after this procedure. Bars: (A) 0.2 #m; (B) 0.1 #m. 
Results 
Secretory Processes in Thyrotrophs of the 
Thyroidectamized Rat Pituitary 
In pituitary glands of normal rats the thyrotrophs, or TSH 
producing cells, are a minority population, but after thyroid- 
ectomy they increase in number, enlarge dramatically (up to 
10x normal), and predominate (8, 9, I0) due to hyperstimu- 
lation as a consequence of the removal of the negative feed- 
back control on TSH secretion. Most of the enlargement of 
these cells results from ballooning of the ER due to a partial 
block in ER to Golgi transport of secretory proteins (21). 
The dilated ER appears as giant vacuoles by light microscopy 
(Fig.  1 A).  Normally TSI-I-cr is synthesized in excess and 
when TSH-/3 is synthesized it dimerizes with TSH-ot, rapidly 
exits the ER (18), and is transported to the Golgi where the 
protein is packaged into granules (21).  However, in thyroid- 
ectomized animals TSH-/3 synthesis increases, and this sub- 
unit accumulates in the ER (22). With increasing time after 
thyroidectomy the  ER  cisternae  also  contain  increasing 
numbers of ICG (Fig.  1, C and D) that are in general larger 
(200-500 nm) than secretion granules (100-200 nm). 
When thyroidectomized rats are treated with T4 the size 
of the ER cisternae gradually diminishes over time due to 
transport of secretory proteins out of the ER and their pack- 
aging into granules (8, 9). This leaves behind the ICG which 
must be disposed of. Over the course of the first 2-4 d of 
treatment, many of the ICG appear to be taken up and dis- 
posed of in lysosomes (8, 9). There is no evidence this occurs 
by autophagy-that is, there is no morphologic evidence of 
wrapping of the ER cisternae containing ICG with smooth- 
surfaced cisternae as described in the liver (2, 6,  12) or in 
pancreatic exocrine cells (32). 
ER Cisternae Initially Lose Ribosomes and Acquire a 
Thicker Membrane 
To obtain information on the mechanism of ICG disposal we 
studied thyrotrophs from thyroidectomized animals treated 
(2-4 d) with T4 in routine Epon sections. In such sections 
multiple ER cisternae could be seen that contained one or 
more ICG (Fig.  1, C and D). However, most ER cisternae 
containing ICG had some of the properties ascribed to tran- 
sitional elements in that they were part rough/part smooth. 
The ribosomes were typically present in patches or clusters 
separated by smooth areas rather than uniformly distributed 
over the entire membrane (arrows,  Fig.  1 C).  In addition, 
structures  which  appeared to  represent intermediates be- 
tween ribosome-studded, ER cisternae containing ICG and 
The Journal of Cell Biology,  Volume 119, 1992  88 Figure 3. (.4) Double immunogold  labeling for TSH-ot  (5 nm gold) and TSH-/~  (8 nm gold). ICG in the Eli (er) or in early (Type  1) intermedi- 
ates are labeled only with TSH-~ (large gold), whereas both TSH-t~ (small gold) and TSH-/~ subunits are detected in secretion granules 
(sg). Enlargement of several secretion granules demonstrating the presence of both TSH-B (large gold) and TSH-a (small gold, arrow- 
heads).  Bars: (A, B, and C), 0.1 /zm. 
fully condensed lysosomes containing barely recognizable 
ICG were frequently seen (Fig. 1, C and D). Based on mor- 
phologic criteria a series of  intermediates could be identified 
in what is apparently a continuous process. For convenience 
these intermediates were divided into two main types, type 
1 and type 2. 
The early or type 1 intermediates (Figs.  1, C and D, and 
2-4) resembled ER cisternae in that they contained one or 
multiple ICGs with the same density as those in the rough 
ER cisternae-i.e., they were quite compact with fine granu- 
lar or fibrous material at their periphery. The main morpho- 
logic differences between these early intermediates and bona 
fide ER cisternae were that they lacked ribosomes, their con- 
tent was typically  denser, their shape more polymorphic, and 
their membrane thicker (8-9  nm) than the ER membrane 
(6-8  nm)  (Fig.  2  A).  No  ribosome-free,  ICG-containing 
cisternae could be found that possessed a thin, ER-like mem- 
brane. It appears, therefore, that ribosomes detach from the 
rough ER, and the latter acquires a thicker membrane. 
The late or type 2 intermediates had many of the same fea- 
tures as the type 1, but the outlines of the ICG were less 
sharp, and their content was usually somewhat denser and 
more polymorphic (Fig. 1, C and D). There was sometimes 
evidence of beginning dispersion of the ICG at their periph- 
ery.  Also,  when multiple ICG were  seen within a  single 
cisterna they were often aggregated into clusters (Fig.  1, C 
and D).  Occasionally images were encountered suggesting 
that fusion takes place between type 1 and type 2 intermedi- 
ates (Fig. 2 B). In no case was there any evidence of  a double 
membrane or enveloping cisterna surrounding these struc- 
tures comparable to that surrounding forming autophagic 
vacuoles. All of the intermediates had a single thick mem- 
brane. 
These observations suggested that ER cisternae containing 
ICG are gradually modified by a progressive process during 
which  they lose  their  ER  characteristics  (attached  ribo- 
somes; thin membrane; content of low density) and gradu- 
ally acquire lysosomal characteristics (smooth, thick mem- 
brane; heterogeneous, dense content). They raised a number 
of questions concerning the nature of the membranes and 
content of the ER cisternae and intermediates containing 
ICG. To answer these questions we turned to immunocyto- 
chemistry. 
Intracisternal Granules Contain TSH-[3 
We first set out to determine the nature of the ICG. Toward 
this end we labeled sections of T,-treated (4 d) thyroidec- 
tomy ceils with antibodies that recognize TSH-ct and TSH-~. 
TSH is a heterodimer with the ~ subunit being specific for 
TSH and the a  subunit shared in common with several other 
glycoprotein hormones (follicle stimulating and luteinizing 
hormones and chorionic gonadotropin). By immunofluores- 
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Labeling 
w  Type 1  Type  2  Lysosome  Secretory  granule 
TSH-/~  +  +  +  + 
TSH-ot  .... 
PDI  +  +  -  - 
KDEL  +  +  -  - 
ER membrane  +  +  +  + 
proteins 
Lgpl20  -  +  +  + 
Cathepsin D  -  -  +  + 
AcPase-E*  -  +  +  + 
AcPase-I~  -  -  +  + 
+ 
+ 
B 
m 
* AcPase-E: AcPase activity detected by enzyme  cytoehemistry. 
~: AcPase-I: AePase immunoreactivity  detected by immunogold  labeling. 
w  RER, type 1 and type 2 intermediates, lysosomes, and secretory granules 
were identified by morphologie  criteria described in the Results. With the ex- 
ception of AcPase-E, presence or absence of labeling is based on the presence 
or absence of gold particles over a given organdie. Labeling for AcPase-E  is 
based on the presence  or absence  of lead phosphate reaction  product. "+" indi- 
cates organelle designated is regularly labeled for a given marker. "-" indi- 
cates organelle is not labeled above background. ":1:" indicates occasional 
labeling is seen. 
cence, the dilated ER cisternae of thyrotrophs were weakly 
labeled  for  TSH-/$,  and  the  surrounding  cytoplasm  was 
strongly stained (not shown).  By immunngold procedures, 
heavy gold labeling was found over the ICG and secretion 
granules (Fig. 3, A, B, and C). The remaining luminal con- 
tents of the ER and Golgi elements were lightly labeled.  It 
was  apparent  that  the  strong  cytoplasmic  immunofiuores- 
cence was due to heavy labeling of secretion granules which 
Showed the heaviest concentration of gold.  Gold particles 
were also found over ICG within type 1 and type 2 intermedi- 
ates (Fig. 3 A and see Fig. 7 B), but few if any were found 
over lysosomes (summarized in Table I). 
By contrast TSH-a was detected  only in secretion gran- 
ules: the cytoplasm surrounding the dilated ER cisternae was 
stained by immunofluorescence, and only the secretion gran- 
ules were significantly labeled by immunogold procedures 
(Fig. 3, A, B, and C). Since these cells are known to synthe- 
size and secrete TSH-~, one would expect to detect TSH-c~ 
in the ER. The lack of reactivity could be due to: (a) its low 
ER concentration as a result of rapid transit of TSH-c~ to the 
Golgi; (b) low sensitivity of the TSH-ot antisera; or (c) fail- 
ure  of the  antiserum  to  recognize  the  ER  form  of this 
subunit. 
We conclude that  ICG consist of aggregates containing 
TSH-~, and therefore TSH-~ provides a convenient marker 
for ICG. 
ER Content and Membrane Markers Are Found in 
type I and 2 Intermediates 
We next wanted to know if type 1 and type 2 intermediates 
contained ER markers.  To obtain information on this point 
we carried out labeling for ER membrane and content pro- 
teins. By immunofluorescence two ER content markers, anti- 
PDI (Fig.  1  B)  and anti-KDEL (not shown), were concen- 
trated in the dilated ER of thyrotrophs, with the intensity of 
labeling varying from one cell to another. By immunogold, 
the contents of the dilated ER cisternae were immunoreac- 
tire, but the ICG were not labeled (Fig. 4 C). These two ER 
content markers were also detected in the contents of type 
1 intermediate  structures  (Fig. 4  C). 
The findings  by immunofiuorescence were very similar 
with an anti-ER serum that recognizes four ER membrane 
proteins in NRK cells (16): staining was concentrated in the 
contents of the dilated  ER cisternae  (Fig.  4, A  and B).  It 
was  surprising to find that the contents of the  dilated  ER 
cisternae of thyrotrophs were reactive with an antiserum that 
recognizes ER membrane proteins. When this was checked 
at the EM level by immunogold labeling, gold particles were 
seen over both the membranes and contents of ER and type 
I  and type 2  intermediates  in thyrotrophs (Figs. 4  E  and 5, 
A-D).  However, in other anterior pituitary cells (Fig. 4 D) 
it  was  predominantly  on  the  ER membranes  (rather  than 
their  contents).  The  findings  establish  that  intermediate 
structures  with  ICG  contain  ER  membrane  and  content 
markers.  The fact that labeling of the ER lumen is seen in 
thyrotrophs but not in other cell types, suggests that in hyper- 
stimulated  thyrotrophs one or more of the  ER membrane 
proteins  recognized  by  the  antibody  undergoes  cleavage 
releasing its  ectodomain into the ER lumen. 
Co-Localization  of  ER Markers and a Lysosomal 
Membrane Protein in Intermediates 
We next wish to determine whether both ER and lysosomal 
proteins  could be detected in the same intermediate  struc- 
tures. We found that an antibody against the lysosomal mem- 
brane protein,  lgpl20,  labeled  not only the membranes of 
lysosomes (Fig. 5 C), but also the membranes of type 1 and 
2  intermediates  with clearly recognizable ICG (Figs.  5, A, 
B, and D and 6, A and B). In fact, the membrane of any struc- 
ture containing ICG that lacked ribosomes was immunoreac- 
Figure 4. Distribution of ER markers in a T4-treated,  thyroidectomized rat pituitary.  (,4 and B) Phase contrast and immunofluomscence 
micrographs demonstrating labeling  of thyrotrophs (16). Semithin  cryosections were reacted with an anti-ER antiserum that recognizes 
four ER membrane proteins.  Surprisingly,  the contents  of the dilated  ER cisternae (er) of many of the thyrotrophs are strongly labeled 
(*). Diffuse cytoplasmic staining is also seen in several other cell types, and one thyrotroph (T) shows prominent labeling of the ER mem- 
brane (arrowhead), but the strongest labeling  is seen within the dilated ER of thyrotrophs. The presence of immunoreactivity in the ER 
lumen suggests that ER membrane proteins are cleaved and released into the lumen of the modified ER. (C) Immunogold labeling demon- 
strafing localization of PDI within the contents of two ER cistemae (er) and an early (Type 1) intermediate.  The ICG within these compart- 
ments are not labeled.  The type 1 intermediates  can be distinguished  from ER cisternae by the greater density of their contents (*). (D 
and E) Immunogold labeling with anti-ER antiserum. In a mammosomatotroph (shown in D) most of the gold particles are closely as- 
sociated with membranes of  the rough ER which is in keeping with the fact that the four proteins recognized by this antiserum are membrane 
proteins.  In the thyrotroph, however (shown in E), these ER membrane antigens are detected in the ER contents and in the contents (arrow- 
heads) of early (Type I) intermediates  as well as associated with ER membranes (arrows). Little  labeling  of the lysosome (/y) is seen 
above background. Bars: (A and B)  10 #m; (C) 0.1 #m; (D) 0.2 #m; (E) 0.1 #m. 
The Journal of Cell Biology, Volume 119, 1992  90 Noda and Farquhar Diversion of ER Proteins to Lysosomes  91 Figure 5. Double immunogold labeling for  the lysosomal marker, lgpl20 (5 nm gold), and ER markers (15 nm gold). (.4)  A type 1 intermedi- 
ate whose membrane and contents (a~ads)  are labeled with an antibody raised against ER membrane proteins and whose membranes 
are weakly reactive for lgpl20 (arnnvs, small gold). (B, C, and D) Type 2 intermediates and lysosomes (ly) whose membrane and contents 
are labeled with the anti-ER antiserum (large gold) and whose membranes are labeled for lgp 120 (small gold). Bars, 0.1 /~m. 
five for lgpl20. When double labeling was done with anti- 
PDI or anti-ER antisera and anti-lgpl20, type 1 and type 2 
intermediates (Figs. 5, A-D and 6 B) were regularly labeled 
with both organelle markers. Counts of gold particles over 
intermediates in the same field indicated that labeling for ER 
markers declined and labeling for lgpl20 increased as the 
ICG contents became less distinct, which presumably corre- 
sponds to the conversion of a type 1 to a type 2 intermediate. 
Particularly significant was the co-localization of both ER 
membrane proteins and lgpl20 in the membrane of the same 
early intermediate (Fig. 5 A) with compact ICG. These data 
indicate that ER cisternae acquire lysosomal membrane pro- 
teins very early, before loss of ER membrane and content 
proteins. 
Lysosomal Enzymes Are Detected in Intermediates As 
Well As Lysosomes 
To determine the distribution of lysosomal enzymes, AcPase 
The Journal of Cell Biology,  Volume 119,  1992  92 Figure 6. Immunogold labeling for the lysosomal membrane protein, lgpl20. (A) Two early (Type 1) intermediate structures are seen: 
one shows little labeling and the other moderate labeling (arrows) for lgpl20 along its limiting membrane. A more advanced (Type  2) inter- 
mediate is heavily labeled. (B) Double labeling for lgpl20 (5 nm gold) and PDI (15 nm gold). An early (Type  1) intermediate with several 
ICG (lcg) contains both the ER content marker (large gold) and the lysosomal membrane marker (arrows, small gold). Bars, 0.1 t~m. 
and cathepsin D  were localized by immunocytochemistry. 
The distribution of both enzymes was similar as both were 
found in  lysosomes and  in type 2  intermediates, but they 
were not seen in type 1 (Fig.  7, A and B). When double- 
labeling was carried out with anti-lgpl20 and anti-AcPase or 
anti-cathepsin D, many type 1 intermediates were identified 
which  showed membrane labeling  for lgpl20,  but  lacked 
labeling for lysosomal enzymes (not shown). 
When  AcPase  activity  was  localized using  an  enzyme 
cytochemical reaction (Fig.  8, A and B), reaction product 
was detected in the same compartments as after immunocy- 
tochemical localization- i.e., in late or type 2 intermediates 
and in lysosomes. However, by enzyme cytochemistry the 
transmost Golgi cisterna and some type 1 intermediates were 
also AcPase positive (Fig.  8 A). 
When double immunogold labeling was  carried out for 
TSH-# and either AcPase or cathepsin D using two sizes of 
colloidal gold, both TSH-/~ and the lysosomal enzymes could 
be detected in  intermediate structures,  with TSH-~ being 
localized to ICG and lysosome enzymes to their remaining 
contents (Fig.  7 B). 
From these results (summarized in Table I) we conclude 
that  intermediates  containing  ICG  acquire  the  lysosomal 
membrane protein lgpl20 before the acquisition of lysosomal 
enzymes. A similar sequence occurs during formation of au- 
tophagic vacuoles (32). 
MPR Are Not Involved in Delivery of  Lysosomal 
Enzymes to ER Cisternae 
When  we  carried  out  labeling  for  MPR  there  was  no 
significant immunoreactivity detected in the Golgi complex, 
ER, or endosomes of thyrotrophs cells with two different an- 
tibodies to the receptor. Labeling was seen however, in endo- 
somes in other cell types in the same field. This suggests: 
(a) that the overall level of  expression of MPR in hyperstimu- 
lated thyrotrophs is  rather low;  and (b) that this  receptor 
may not be involved in the delivery of lysosomal enzymes to 
the ER. 
Discussion 
We have used immunocytochemical markers for ER, lyso- 
somal, and secretory proteins to investigate the mechanism 
of disposal of ICG in thyrotrophs of the thyroidectomized, 
T4-treated rat. By morphology alone, we were able to dis- 
tinguish intermediates in what appeared to be a continuous 
process  involving direct conversion of ER  cisternae  into 
Noda and Farquhar Diversion of ER Proteins to Lysosomes  93 Figure 7. Immunogold localization of cathepsin D (8 nm gold). (A) Two lysosomes (/y) with contents of low density are strongly labeled, 
whereas the ER cisternae (er) and early (Type 1) intermediates are devoid of label. (B) Double labeling for cathepsin D (8 nm gold) and 
TSH-/3 (15 nm gold) demonstrating colocalization of a lysosomal enzyme (arrowheads) and TSH-/3 in a type 2 intermediate. Secretion 
granules (sg) are labeled only with TSH-/3 (large gold). Bars, 0.5 #m. 
lysosomes. Based on our immunocytochemical localizations 
of ER and lysosomal markers we distinguished two main 
types of intermediates-type 1 and type 2  (Table I). From 
our combined morphologic and  immunocytochemical re- 
suits we can reconstruct the process for disposal of ICG as 
follows (Fig. 9): An ER cisterna with some of the properties 
of transitional elements (part rough/part smooth) containing 
one or more ICG begins to lose its ribosomes, its contents 
become condensed,  and  its  shape  more irregular.  At the 
same time, it appears that some ER membrane proteins un- 
dergo cleavage and are released into the ER lumen.  Con- 
comitantly the ER cisternae acquire a thicker, lysosome-type 
membrane. These early or type 1 intermediates are identi- 
fied by the presence of clearly recognizable ICG, ER content 
markers  (PDI  and  other KDEL-containing proteins),  ER 
membrane proteins, and the lysosomal membrane protein, 
lgpl20, but they lack lysosomal enzymes. Type 1 intermedi- 
ates gradually become more condensed, the profiles of the 
ICG become less sharp, and they acquire lysosomal enzymes 
as  demonstrated by immunogold labeling for AcPase and 
cathepsin D. That AcPase is enzymatically active was dem- 
onstrated by enzyme cytochemistry. It is  the presence of 
lysosomal enzymes that distinguishes type 2  or late inter- 
mediates from type 1 (see Table I). The ICG within type 2 
intermediates begin to disperse at their periphery and even- 
tually can no longer be recognized within the dense contents. 
In the strict sense, a structure becomes a lysosome when it 
acquires lysosomal enzymes, but, as already indicated, the 
conversion of an ER cisterna to a lysosome is a continuous 
process and the delineation of type 1 and type 2 structures 
and lysosomes is somewhat arbitrary. We distinguish late in- 
termediates from lysosomes by the presence of still recogniz- 
able ICG. Fully mature lysosomes contain barely recogniz- 
able ICG or have a homogeneous content in which specific 
digestive  residues  cannot  be  recognized.  Membranous 
whorls  or  myelin figures,  commonly  seen  in  autophagic 
vacuoles, are rarely seen in lysosomes of thyrotrophs. 
The process we have described for the direct conversion 
of an ER cisterna to a lysosome is novel. The only previous 
study dealing with ICG disposal was in the exocrine  pancreas 
of guinea pigs treated with COC12 which causes massive in- 
duction of ICG that are eventually disposed of by autophagy 
(32). Is it possible that in our case disposal also occurs by 
autophagy, but we have not been able to detect the earliest 
stage of autophagic vacuole formation? We do not consider 
this likely, as multiple rat pituitaries were investigated over 
a period of 1-4 d after thyroidectomy and '1"4  treatment, and 
images suggesting the presence of an enveloping cisternae 
were rare, whereas they are not difficult to detect in other 
situations where autophagy occurs.  Moreover, autophagic 
The Journal of  Cell  Biology, Volume  119, 1992  94 Figure 8. Enzyme cytochemieal localization of AcPase. Heavy deposits of acid phosphatase reaction product are seen in lysosomes (ly), 
in the transmost cisterna of the Golgi complex (G), and around the ICG in type 2 intermediates (inset, B). A weaker reaction is present 
in early (Type 1 ) intermediates. The ER cistemae (er) are not reactive. Bars, 0.2 #m. 
vacuoles are  usually readily identified by their heteroge- 
neous content which often includes ER cisternae, mitochon- 
dria, and other membranous residues (myelin figures) (2, 6, 
12, 32) that are not seen in the ICG-containing type 1 or type 
2  intermediate structures or in lysosomes in thyrotrophs. 
Thus it appears that two different mechanisms exist for dis- 
posal of ICG in the exocrine pancreatic cell and in the pitu- 
itary thyrotroph. In the case of the thyrotroph the lysosomal 
disposal mechanism may serve to degrade the TSH-/3 that 
was made in excess during thyroidectomy  and did not dimer- 
ize with TSH-c~. 
Our findings provide compelling evidence that a mecha- 
nism exists for disposal not only of ICG, but also of other 
ER proteins by direct conversion of an ER cisterna into a 
lysosome. Two questions are left unanswered by our data. (a) 
What is the mechanism by which the ER membrane is con- 
verted into a lysosomal membrane?; and (b) How do the ER 
cisternae acquire lysosomal enzymes? In regard to the first 
question, the membrane could come from direct fusion with 
preexisting lysosomes; however the membrane change oc- 
curs very early and there is no evidence of fusion of ER 
cisternae with lysosomes, although images suggesting fusion 
between type 1 and type 2 intermediates are sometimes seen. 
During autophagic vacuole formation in the liver (6, 7,  12) 
the enveloping cisterna that initiates the autophagic event is 
also derived from a rough ER cisterna that loses its ribo- 
somes, undergoes structural changes, envelopes cytoplasmic 
components, and rapidly acquires lysosomal membrane pro- 
teins. In neither case is the basis for the conversion of an ER 
membrane to a  lysosome membrane known, but one can 
speculate that membrane replacement occurs via fusion of 
small vesicles carrying lysosomal membrane constituents 
with these special transitional elements of the ER. 
The second question left unanswered by our findings is the 
mechanism of delivery of lysosomal enzymes to the ER cis- 
ternae. It seems unlikely that cation-independent MPR are 
involved since they could not be detected in these structures. 
Among the existing possibilities are that the enzymes are: (a) 
acquired by direct fusion with preexisting lysosomes; (b) fer- 
ried there via the 46 kD (cation-dependent) mannose-6-phos- 
phate receptor; (c) newly synthesized enzymes from the ER 
itself; or (d) targeted by an unknown delivery mechanism. 
Since images suggesting fusion between type 1 and type 2 
structures are sometimes seen (Fig. 2 B), we consider the 
first possibility the most likely. Experiments of the type car- 
tied out by Tooze et al. (32) with MPR fragments conjugated 
to gold could help to determine whether the lysosomal en- 
zymes present in the intermediate structures were newly de- 
livered with the mannose-6-phosphate recognition marker 
still intact or had already undergone processing to remove 
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Figure 9. Diagram depicting the proposed degra- 
dative pathway for ICG in thyrotrophs of the rat 
pituitary. In the thyrotroph of normal rats, the 
rough ER is organized into flattened cisternae 
(upper left),  After thyroidoctomy (TX) which 
causes increased TSH secretion, the ER lumen 
becomes dilated and ICG form. Upon "1"4  treat- 
ment which shuts off  TSH secretion, some of  the 
TSH stored in the ER lumen is transported to the 
Golgi complex and packaged into secretory gran- 
ules, whereas the ICG which cannot be trans- 
ported along the secretory pathway are degraded 
in lysosomes. This appears to occur by direct 
conversion of an ER cisterna into a lysosome in 
several steps as follows: A part rough/part smooth 
ER cisterna which is heavily labeled with ER 
markers (PDI, KDEL, ER membrane proteins) 
loses its ribosomes, its contents  become more con- 
densed, and ER membrane proteins are cleaved 
and released into the lumen. At the same time the 
membrane is converted into a thick, lysosomal- 
type membrane which contains lgpl20, a lyso- 
somal membrane protein,  which completes its 
transition to a type 1 intermediate. The structure 
then receives lysosomal enzymes such as AcPase and cathepsin D (to become a type 2 intermediate) which is arbitrarily distinguished 
from a lysosome by the presence of  recognizable ICG. Lysosomal enzyme delivery is believed to be accomplished by fusion between type 1 
intermediates and either type 2 intermediates or lysosomes. Based on the fact that the lysosomal membrane protein,  lgpl20,  can be 
co-localized with ER membrane proteins on the limiting membranes of  type 1 and 2 intermediates as well as lysosomes, the transformation 
of the ER to a lysosome is assumed to occur by a progressive direct conversion process. 
it, but they would not provide information on the route of ly- 
sosomal enzyme delivery. Evidence for involvement of (ca- 
tion-independent) MPR in autophagy was obtained in the ex- 
periments of  both Dunn (6, 7) and Tooze et al. (32). However, 
in another model of autophagy (induced by leupeptin treat- 
ment),  Dunn (6,  7) found no evidence for involvement of 
these receptors. This indicates that MPR are not necessarily 
involved  in  lysosomal  enzyme  delivery  in  all  cases  of 
lysosomal digestion.  It has  already been established  that 
some lysosomal enzymes such as AcPase reach lysosomes 
via the trans-Golgi by mechanisms that do not involve MPR 
(28,  33). 
Protein Degradation  in the ER 
It has become evident that considerable turnover of newly 
synthesized proteins occurs in the ER. Some of this is related 
to normal turnover of ER resident proteins (5, 27), and some 
is related to the newly discovered function of the ER in dis- 
posing of unassembled subunits of multirneric proteins (1, 
14,  15) and aggregated or misfolded, transport incompetent 
proteins (13, 14). Very little is known regarding the mecha- 
nisms by which either resident proteins or those in transit are 
degraded.  Both lysosomal and nonlysosomal mechanisms 
have been claimed to exist based on the sensitivity (14, 27) 
or lack of sensitivity (1, 5,  15), respectively, of the process 
being studied to lysosomotrophic agents (primaquine, chio- 
roquine). The only direct information on lysosomal involve- 
ment comes from the experiments of Tooze et al.  (32) al- 
ready  summarized  and  experiments  on  two  resident  ER 
enzymes indicating that the half-life of glucosidase II (27) 
and HMG-CoA reductase (5) was doubled in the presence 
of lysosomotrophic agents. This suggests that lysosomes are 
involved in the turnover of these two enzymes. In the case 
of glucosidase H it was suggested (27) that disposal was by 
autophagy based on earlier immunocytochemical observa- 
tions (17). 
Our findings as well as those of Dunn (6, 7) are compatible 
with the assumption that the distal (preGolgi) regions of the 
ER  where  transitional  elements are  found may represent 
areas of specialization which under some circumstances can 
participate  in the diversion of secretory proteins and ER 
membrane and content proteins to lysosomes. The validity 
of this hypothesis remains to be established. 
From the general standpoint it is of interest that in pitu- 
itary cells secretory proteins can be diverted to lysosomes 
at several intracellular sites along the exocytic pathway.  In 
addition to the ER mechanism for disposal of ICG described 
here, both immature and mature secretory granules can be 
disposed of in lysosomes by crinophagy. This is the process 
by which mature secretory granules can fuse directly with 
lysosomes, and immature granules can fuse with multivesic- 
ular endosomes and be degraded (9,  26).  Thus both pre- 
Golgi and post-Golgi sites exist for regulation of the secre- 
tory process through lysosomal degradation. 
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